Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.

Biotechnology

Pyxis Oncology

Lara S. Sullivan

Weitang Chen

Leah Lyons

Greg Parry

Michael Dyszel

Aaron Moses

Jitu Wadhane

Anna Dixon

Michael Bui

Ken Kobayashi

Xiaodong Yang

Balu Balasubramanian

Jan Pinkas

Pamela Connealy

The executive team at Pyxis Oncology has a history of working in the fields of development and consulting. They have a wealth of experience in these areas and also hold degrees in protein biochemistry, marine biology, and biotoxinology.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Pyxis Oncology

Board of Directors

Leadership Team